This conversation between Daphne Koller and Joel Hellermark was recorded in April 2024 at the insitro’s headquarters in San Francisco. An edited version was premiered at Sana AI Summit on May 15 2024 in Stockholm, Sweden.

Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company. Daphne was the Rajeev Motwani Professor of Computer Science at Stanford University, the co-CEO and president of Coursera, and the recipient of numerous prestigious prizes in computing and engineering, including the MacArthur Foundation Fellowship.

Joel Hellermark is the founder and CEO of Sana. An enterprising child, Joel taught himself to code in C at age 13 and founded his first company, a video recommendation technology, at 16. In 2021, Joel topped the Forbes 30 Under 30. This year, Sana was recognized on the Forbes AI 50 as one of the startups developing the most promising business use cases of artificial intelligence.

Timestamps
Early days of AI (00:00:00)
Intersecting biology & AI (00:04:12)
Predicting biology (00:06:22)
insitro’s vision (00:10:12)
Harmonizing datasets (00:12:30)
Finding patterns (00:13:53)
Addressing biases (00:15:39)
Importance of finetuning (00:17:02)
Layers of multimodality (00:19:35)
Actionable insights (00:21:34)
Bilingual colleagues (00:23:57)
Biologists’ future (00:26:14)
Eroom’s Law (00:29:25)
Lack of data (00:34:57)
Incentivizing scientists (00:39:51)
Daphne’s motivation (00:43:56)
Future of medicine (00:46:40)

Follow Sana
X - [ Ссылка ]
LinkedIn - [ Ссылка ]
Instagram - [ Ссылка ]
Try Sana AI for free - [ Ссылка ]

свернуть